medigraphic.com
ISSN 0016-3813 (Print)

2001, Number 6

<< Back Next >>

Gac Med Mex 2001; 137 (6)

Early and Intermediate Improvement as Predictors of Response to Antidepressant Treatment.

Berlanga C, Caballero A, Apiquián R

Language: Spanish
References: 27
Page: 521-527
PDF size: 66.67 Kb.


ABSTRACT

An important limitation in the treatment of depression is the lack of reliable factors for predicting treatment response. Most of these factors have been related to biological and clinical aspects. A clinical aspect that has proved to reasonably predict long-term efficacy is early response. An adequate early response predicts a good outcome at the long term. The purpose of this study was to quantify the proportion of patients who show no response to a fixed dose of antidepressants after 2,4, and 6 weeks of treatment, and then respond by week 8. Additionally, a subgroup of patients was followed using the same methodology until 12 weeks of treatment. A lack of response by weeks 4 and 6 predicted a final lack of response both at weeks 8 and 12 of treatment. Alternatively, a robust response as early as week 2 predicted a good response by the end of the two treatment periods. These findings should help clinicians revalorate treatment when finding no response after 4 or 6 weeks of treatment.


REFERENCES

  1. 1. Angst J. How current and predictable is depressive illness? In: Montgomery SA, Rouillon F, editors. Long-term treatment of depression. Chichester, UK; Wiley Press; 1992. p. 1-14.

  2. 2. Nemeroff CB, Schatzberg AF. Pharmacological treatment of unipolar depression. In: Nathan PE, Gorman JM, editors. Treatments of DSM IV disorders. New York: Oxford University Press; 1997. p. 210-223.

  3. 3. Donovan S, Quitkin F, Stewart J, et al. Duration of antidepressant trials: clinical and research implications. J Clin Psychopharmacol 1994;14:64-66.

  4. 4. Quitkin FM, Rabkin JG, Ross D, et al. Duration of antidepressant drug treatment: what is an adequate trial? Arch Gen Psychiatry 1984;238-245.

  5. 5. Nierenberg AA. Treatment choice after one antidepressant fails: a survey of Northeastern psychiatrists. J Clin Psychiatry 1991;52:383-385.

  6. 6. Coryell W, Turner R. Outcome with desipramine therapy in subtypes of nonpsychotic major depression. J Affect Disord 1985;9:149-154.

  7. 7. Arana GW, Baldessarini RJ, Ornesteen M, et al. The dexamethasone suppression test for diagnosis and prognosis in psychiatry: commentary and review. Arch Gen Psychiatry 1985;42:1193-1204.

  8. 8. Maas JW, Kocsis JH, Bowden CI. Pre-treatment neurotransmitter metabolites and response to imipramine and amitriptyline treatment. Psychol Med 1982;12:37-43.

  9. 9. Van Praag HM, De Maan S. Depression, vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatry Res 1980;3:75-83.

  10. Langer G, Köning G, Hatzinger R, et al. Response of thyrotropin to thyrotropin-releasing hormone as predictor of treatment outcome. Arch Gen Psychiatry 1986;43:861-868.

  11. Van Kammen DP, Murphy DL. Prediction of imipramine antidepressant response by a one day d-amphetamine trial. Am J Psychiatry 1978;135:1179-1184

  12. Paykel ES, Klerman GL, Prusoff BA. Prognosis of depression and the endogenous-neurotic distinction. Psychol Med 1974;4:57-64.

  13. Jarrett RB, Eaves G, Grannemann BD, et al. Clinical, cognitive and demographic predictors to cognitive therapy for depression: a preliminary report. Psychiatry Res 1991;37:245-260.

  14. Murphy JE. The prognosis of depression in old age. Br J Psychiatry 1983;142:111-119.

  15. Raskin A, Boothe H, Schulterbrand JG, et al. A model for drug use with depressed patients. J Nerv Ment Dis 1973;156:120-124.

  16. Brown RP, Sweeney J, Frances A. Age as a predictor of treatment response in endogenous depression. J Clin Psychopharmacol 1983;3:176-178.

  17. Klerman GL, Weissman MM, Prusoff BA, et al. RDC endogenous depression as a predictor of response to antidepressant drugs and psychotherapy. In: Costa E, Racagni G, editors. Typical and atypical antidepressants. Clinical practice. New York: Raven Press; 1982. p. 165-178.

  18. Volz HP, Müller H, Sturm Y. Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks. Psychiatry Res 1995;58:107-115.

  19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC, USA: American Psychiatric Association; 1994.

  20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.

  21. Nierenberg AA, Farabaugh AH, Alpert JE, et al. Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry 2000;157:1423-1428.

  22. Siegel S. Estadística no paramétrica aplicada a las ciencias de la conducta. México: Editorial Trillas; 1976.

  23. Berlanga C, Arechavaleta B, Heinze G, et al. A double-blind comparison of nefazodone and fluoxetine in the treatment of depressed outpatients. Salud Mental 1997;20(3):1-8.

  24. Nierenberg AA, McLean EN, Alpert JE, Worthington JJ. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 1995;152:1500-1503.

  25. Katz M, Koslow S, Maas J, et al. The timing, specificity and clinical prediction of tricyclic drug effect in depression. Psychol Med 1987;17:297-309.

  26. Quitkin FM, Stewart JW, McGrath PH, Nuñez E, et al. Loss of drug effects during continuation therapy. Am J Psychiatry 1993;150:562-565.

  27. Müller H, Möller HJ. Methodological problems in the estimation of the onset of the antidepressant effect. J Affect Disord 1998;48:15-23.




2020     |     www.medigraphic.com